PharmaReports: Pain
LeadDiscovery offers full reports in selected areas of the pharmaceutical and biotech sector.
Each of the reports below has been especially selected by LeadDiscovery. Browse the reports or try our search engine.
This channel focuses on the major pain etiologies. In addition reports relating to migraine and occasionally IBS will be found in this channel.
Showing results 1 - 50 of 105
- The World Market for Pain Management Drugs and Devices
- The Global Market for Adjunctive Therapies in Cancer
- The U.S. Market for Over-the-Counter Pediatric Medication and Healthcare Products
- Diabetes and Diabetic Complications: Major World Markets
- Cancer Therapeutics: The Worldwide Market
- Pain Therapeutics - Drugs, Markets and Companies
- Personalized Medicine - scientific and commercial aspects
- Nitric Oxide - Therapeutics, Markets and Companies
- Drug Delivery in Central Nervous System Diseases - technologies,markets and companies
- Stem Cell Markets
- Cannabinoid Market Forecasts & Analysis to 2012
- Early Toxicology: Markets and Approaches
- Osteoarthritis - Market sees steady growth
- Migraine - Innovation essential as weak late-stage pipeline fails to hold off the impact of triptan patent expiries
- Breakthrough Pain - Fast-acting players will capture majority market share
- Osteoarthritis - The Wait for a DMOAD Continues
- Biotech Drug Delivery Systems - Key Company Intelligence & Market Outlook to 2012
- Neuropathic Pain - A Plethora of Patient Segmentation and Product Differentiation Opportunities
- From Blockbuster to Nichebuster
- Monoclonal Antibodies 2007
- The Global Protein Therapeutics Market
- Biogenerics
- Pain Therapeutics 2005
- Therapeutic Vaccines
- Orthopedic Postoperative Pain
- Pipeline Insight: Neuropathic Pain
- Endo Pharmaceuticals’ Lidoderm - Physician survey indicates increased use likely to fuel sales
- Anesthesia Drugs: Worldwide Markets
- Stakeholder Opinions: Fibromyalgia - Potentially lucrative market soon to become reality
- Monoclonal Antibodies: Financial and strategic analysis of the mAb market
- Irritable Bowel Syndrome - A potentially profitable market with limited competition
- Drug Discovery Tools for High-Content Analysis
- HEADACHE - Therapy Area Pipeline Report
- MIGRAINE - Therapy Area Pipeline Report
- NEUROPATHY - Therapy Area Pipeline Report
- PAIN - Therapy Area Pipeline Report
- DENTAL PAIN - Therapy Area Pipeline Report
- IRRITABLE BOWEL SYNDROME (IBS) - Therapy Area Pipeline Report
- MUSCLE PAIN - Therapy Area Pipeline Report
- DIABETIC NEUROPATHY - Therapy Area Pipeline Report
- Peripheral Neuropathy and Neuropathic Pain, 2008
- Commercial Insight: Migraine - Opportunities will exist in the wake of generic attack
- Top Companies and Products in the RNA/DNA Therapy Products Market
- Analysis of the Pharmaceutical Market to 2012 - Segmented by Drug Target Family
- Biosimilars Series: Strategic issues - Potential remains uncertain
- Translational Medicine in Biopharmaceutical Research and Development
- The CNS Market Outlook
- The Gastrointestinal Market Outlook to 2012
- Licensing Strategies - Current Pharmaceutical Licensing Trends
- Coxibs - Past Problems and Future Potential
Browse our theraputic areas for other entries:
- Oncology
- Cancer Immunotherapy
- Immunology & Inflammatory Diseases
- Infectious Diseases
- Psychiatric, Addictive & Sleep Disorders
- Pain
- Neurodegenerative & Neuroelectrophysiological Disorders
- Metabolic & Hormonal Disorders
- Cardiovascular Disorders
- GenitoUrinary Tract Disorders
- Technology
- Diagnostics & Devices
- Other Theraputic Areas, Pharmaceutical Strategy and Development